Density of Neurons in the Stomach and Prognosis of Gastric Adenocarcinoma
N/A
N/A
N/A
N/A
N/A
Open (Enrolling)
Both
Stomach Neoplasms
Both
Stomach Neoplasms
Trial Information
Density of Neurons in the Stomach and Prognosis of Gastric Adenocarcinoma
Inclusion Criteria:
- Fifteen patients evaluated- or treated for suspected or verified gastric
adenocarcinoma at the Department of Gastrointestinal Surgery, St Olavs Hospital,
Trondheim University Hospital
- informed consent
Exclusion Criteria:
- General contraindications for endoscopy with biopsies (i.e. bleeding disorders or use
of anticoagulants).
Type of Study:
Interventional
Study Design:
Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Basic Science
Outcome Measure:
Density of PGP9.5 in gastric adenocarcinoma related to TNM stage and survival of stomach cancer
Outcome Time Frame:
5 years
Safety Issue:
No
Principal Investigator
Jon Erik Grønbech, MD PhD
Investigator Role:
Principal Investigator
Investigator Affiliation:
St Olavs Hospital Trondheim University Hospital
Authority:
Norway:National Committee for Medical and Health Research Ethics
Study ID:
210313
NCT ID:
NCT01821196
Start Date:
December 2012
Completion Date:
December 2017
Related Keywords:
- Stomach Neoplasms
- Tumor Markers, Biological
- PGP9.5 protein, human
- adenocarcinoma
- Adenocarcinoma
- Adenocarcinoma, Mucinous
- Neoplasms
- Stomach Neoplasms
Name | Location |
|---|
